跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Cryptoxanthin
首页
药物
Cryptoxanthin
Experimental
Small Molecule
Cryptoxanthin
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
40
H
56
O
CAS 编号
472-70-8
UNII ID
6ZIB13GI33
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Use Of Beta-Cryptoxanthin
申请人: EICHINGER ANNE
优先权: 2004
CN
US
2 件公开
PRE-NATAL BETA-CRYPTOXANTHIN BENEFITS CHILDREN
申请人: AGENCY FOR SCIENCE TECH & RESEARCH SINGAPORE
优先权: 2019
CN
Preparation method of water-soluble cryptoxanthin
申请人: SHANDONG TIANYIN BIOTECHNOLOGY CO LTD
优先权: 2020
CN
HIGHLY BIOAVAILABLE ORAL ADMINISTRATION COMPOSITION OF CRYPTOXANTHIN
申请人: TAKAYANAGI KATSUHIKO
优先权: 2006
US
Osteogenesis promoter containing -cryptoxanthin as the active ingredient
申请人: YAMAGUCHI MASAYOSHI
优先权: 2002
US
2 件公开
STABILIZED BETA CRYPTOXANTHIN-CONTAINING WATER AND THE USE THEREOF
申请人: SASAKI TAKAO
优先权: 2010
US
Beta-cryptoxanthin from plant source and a process for its preparation
申请人: OMNIACTIVE HEALTH TECH LTD
优先权: 2013
CN
US
3 件公开
Extract Solution Comprising a B-Cryptoxanthin Component and Food and Drink Soaps
申请人: TOYO SEIKAN KAISHA LTD
优先权: 2005
CN
US
2 件公开
药物
反馈